Terence Flynn (Morgan Stanley) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Terence Flynn's stock ratings?

About 45% of Terence's ratings were profitable over a one-year hold, with an average return of -0.1% per rating, measured by 13Foresight from historical prices.

Q: How is Terence ranked?

Terence Flynn is ranked #1738 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Terence Flynn

Terence Flynn

Morgan Stanley

Wall Street Analyst

★★★☆☆

#1738

on 13Foresight · ranked by our own returns

45%

Success Rate

-0.1%

Average Return

19 of 42 calls profitable · -4.7% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

🔒 3-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 45% of Terence Flynn's ratings turned a profit when each position was held for 1 year — averaging -0.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

120 Buy 114 Hold 14 Sell

Terence's Stock Coverage 40 ratings · 2026-06-20

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
BIIB Biogen	Jun 18, 2026	HOLD	Strong Buy +25.1% avg upside 51 analysts	$224.00 13.89% Upside	·
AMGN Amgen	Jun 10, 2026	HOLD	Buy -11.6% avg upside 57 analysts	$340.00 0.66% Upside	-0.0%
NRIX Nurix Therapeutics	Jun 08, 2026	BUY	Strong Buy +75.6% avg upside 26 analysts	$36.00 105.11% Upside	·
LLY Eli Lilly & Co	Jun 08, 2026	BUY	Strong Buy -10.5% avg upside 47 analysts	$1344.00 22.25% Upside	-4.4%
GILD Gilead Sciences	Jun 04, 2026	BUY	Strong Buy -4.8% avg upside 66 analysts	$168.00 35.81% Upside	-3.6%
UTHR United Therapeutics	Jun 04, 2026	HOLD	Buy -18.7% avg upside 26 analysts	$516.00 3.91% Downside	+0.7%
ABBV AbbVie	May 31, 2026	BUY	Buy +2.9% avg upside 43 analysts	$278.00 28.49% Upside	+3.9%
BHVN Biohaven Ltd.	May 28, 2026	BUY	Strong Buy +87.5% avg upside 25 analysts	$18.00 32.65% Upside	+32.5%
BMY Bristol-Myers Squibb	May 26, 2026	SELL	Buy +9.1% avg upside 42 analysts	$40.00 26.02% Downside	+4.7%
BNTX BioNTech SE	May 18, 2026	BUY	Strong Buy +50.5% avg upside 26 analysts	$126.00 38.67% Upside	+2.3%
ALMS Alumis Inc.	May 15, 2026	BUY	Strong Buy +63.6% avg upside 11 analysts	$39.00 66.50% Upside	+0.8%
LEGN Legend Biotech	May 13, 2026	BUY	Strong Buy +140.3% avg upside 27 analysts	$48.00 71.90% Upside	+25.1%
PRME Prime Medicine, Inc.	May 13, 2026	HOLD	Strong Buy +209.6% avg upside 16 analysts	—	-6.4%
NTLA Intellia Therapeutics	May 13, 2026	HOLD	Buy +151.9% avg upside 37 analysts	$15.00 4.21% Downside	-15.2%
RCUS Arcus Biosciences	May 11, 2026	HOLD	Strong Buy +38.0% avg upside 20 analysts	$22.00 9.43% Downside	-3.0%
RPRX Royalty Pharma	May 07, 2026	BUY	Strong Buy +4.2% avg upside 15 analysts	$64.00 20.85% Upside	+7.4%
PFE Pfizer	May 06, 2026	HOLD	Buy +34.2% avg upside 45 analysts	$28.00 11.15% Upside	-3.4%
VRTX Vertex Pharmaceuticals	May 05, 2026	BUY	Strong Buy -2.6% avg upside 61 analysts	$616.00 36.32% Upside	+8.2%
MRK Merck & Company	May 01, 2026	HOLD	Strong Buy +10.7% avg upside 43 analysts	$112.00 1.61% Downside	+3.7%
MRNA Moderna	May 01, 2026	HOLD	Hold +6.1% avg upside 38 analysts	$33.00 48.42% Downside	+41.0%
REGN Regeneron	Apr 30, 2026	HOLD	Strong Buy +26.9% avg upside 57 analysts	$788.00 29.13% Upside	-13.9%
JNJ Johnson & Johnson	Apr 15, 2026	BUY	Strong Buy -3.5% avg upside 36 analysts	$283.00 23.86% Upside	-3.8%
OGN Organon	Apr 10, 2026	HOLD	Sell +10.6% avg upside 9 analysts	$9.00 32.98% Downside	+52.2%
ARVN Arvinas Holding Company	Mar 18, 2026	HOLD	Buy +264.5% avg upside 27 analysts	$11.00 43.32% Upside	-30.4%
GPCR Structure Therapeutics, Inc. Sponsored ADR	Feb 27, 2026	BUY	Strong Buy +132.5% avg upside 17 analysts	$126.00 183.14% Upside	-41.9%
CRSP Crispr Therapeutics AG	Feb 17, 2026	SELL	Buy +39.1% avg upside 41 analysts	$33.00 39.07% Downside	-1.7%
CCCC C4 Therapeutics	Sep 21, 2025	HOLD	Strong Buy +330.3% avg upside 19 analysts	—	+36.4%
EDIT Editas Medicine	Dec 13, 2024	HOLD	Buy +407.9% avg upside 33 analysts	—	+75.7%
ALKS Alkermes	Jun 01, 2021	SELL	Strong Buy -17.6% avg upside 34 analysts	$16.00 64.38% Downside	-29.5%
CTMX CytomX Therapeutics	Aug 10, 2020	HOLD	Strong Buy +269.6% avg upside 21 analysts	$12.00 306.75% Upside	-35.6%
DE:MRK Merck KGaA	Aug 03, 2020	BUY	Buy +2.2% avg upside 32 analysts	$91.62 31.16% Downside	·
TSE:BHC Bausch Health Companies	Dec 02, 2019	HOLD	Buy +807.0% avg upside 29 analysts	$42.43 545.84% Upside	·
KLDO Kaleido Biosciences	Mar 25, 2019	BUY	Buy +13249900.0% avg upside 5 analysts	$20.00 19999899.95% Upside	-58.3%
DNTH Dianthus Therapeutics	Mar 25, 2019	HOLD	Strong Buy +8.8% avg upside 29 analysts	$16.00 80.67% Downside	-67.9%
ALNY Alnylam Pharma	Aug 13, 2018	BUY	Strong Buy +23.6% avg upside 51 analysts	$155.00 44.29% Downside	-12.0%
KNSA Kiniksa Pharmaceuticals	Jun 18, 2018	HOLD	Strong Buy -0.2% avg upside 11 analysts	$22.00 60.08% Downside	-22.1%
KYNB Kyntra Bio	Jul 21, 2017	HOLD	Buy +370.8% avg upside 14 analysts	$31.00 362.79% Upside	+86.1%
AGIO Agios Pharma	Jun 13, 2016	HOLD	Strong Buy +73.2% avg upside 29 analysts	$46.00 34.75% Upside	-2.4%
ATRA Atara Biotherapeutics	Nov 18, 2015	HOLD	Buy +79.6% avg upside 18 analysts	$38.00 277.41% Upside	-43.9%
MCRB Seres Therapeutics	Jul 21, 2015	HOLD	Buy +162.2% avg upside 10 analysts	$36.00 444.56% Upside	-14.0%

🔒 35 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Terence Flynn — Frequently Asked Questions

How accurate are Terence Flynn's stock ratings?

Based on the calls 13Foresight could measure, about 45% of Terence's ratings were profitable over a one-year hold, with an average return of -0.1% per rating, or -4.6% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Terence ranked on 13Foresight?

Terence Flynn is currently ranked #1738 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Terence cover?

Terence most recently has ratings on BIIB, AMGN, NRIX, LLY, GILD, UTHR, ABBV, BHVN, BMY, BNTX, ALMS, LEGN and 28 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!